Table 3 Effects of a rapid test for GBS on neonatal exposure to antibiotics compared to usual care
Outcome | Rapid test, n (%) | Usual care, n (%) | Adjusted risk difference (95% CI)1 | Adjusted relative risk (95% CI)2 |
|---|---|---|---|---|
Neonatal (live births only) | (n = 748) | (n = 947) | Â | Â |
Antibiotics for any indication | Â | Â | Â | Â |
 Yes | 244 (33%) | 412 (44%) | − 0.13 (− 0.23, − 0.02) | 0.71 (0.54, 0.95) |
 No | 493 (67%) | 534 (56%) | ||
 Missing | 11 | 1 |  |  |
Antibiotics for suspected early-onset sepsis | Â | Â | Â | Â |
 Yes | 187 (25%) | 374 (39%) | − 0.15 (− 0.26, − 0.04) | 0.63 (0.43,0.92) |
 No | 548 (75%) | 572 (61%) | ||
 Missing | 13 | 1 |  |  |
Neonatal mortality (all neonates)* | (n = 749) | (n = 951) | Â | Â |
 Yes | 3 (0.4%) | 8 (0.84%) |  | 0.48 (0.10, 2.21) |
 No | 746 (99.6%) | 943 (99.16%) | ||
 Missing | 0 | 0 |  |  |